Effective Synthesis of C20‐Epi‐Isothiocyanato‐Salinomycin and its Thiourea Derivatives as Potential Anticancer Agents
Chemistry – A European Journal · 2024
DOI: 10.1002/chem.202402483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2024. Verfasst von Rui Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wu…. Hauptthemen laut MEDLINE: Thiourea, Antineoplastic Agents, Pyrans, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Hubei Province.
Abstract (Originalsprache)
Salinomycin, a naturally occurring polyether ionophore antibiotic isolated from Streptomyces albus , has been demonstrated potent cytotoxic activity against a variety of cancer cell lines. In particular, it exhibits selective targeting of cancer stem cells. However, systemic toxicity, drug resistance and low bioavailability of the drug significantly limit its potential applications. In this study, the C20‐epi‐isothiocyanate of salinomycin was designed and synthesized, and then reacted with amines as a versatile synthon to assemble a series of salinomycin thiourea derivatives, which improved the druggability of salinomycin. The antiproliferative activities of the compounds were evaluated in vitro against A549, HepG2, HeLa, 4T1, and MCF‐7 cancer cell lines using the CCK‐8 assay. The pharmacological results showed that some salinomycin thiourea derivatives exhibited excellent inhibitory activity against at least one of the tested tumor cells and high selectivity. Further mechanistic studies showed that compound 9 f , containing a 3,5‐difluorobenzyl moiety, could directly induce apoptosis, probably by increasing caspase‐9 protein expression and cell cycle arrest in G1 phase in a concentration dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
- CAS Key Laboratory of Science and Technology on Applied Catalysis, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China.
- State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, National Center for Magnetic Resonance in Wuhan, Wuhan Institute of Physics and Mathematics, Innovation Academy for Precision Measurement Scie…
- Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
ORCID-Profile: Zhigang Yang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province
- Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Jiang, R., Zhang, X., Li, N., Mao, Y., Chen, H., Deng, Z., Wang, W., Jiang, Z. X., Xu, L., & Yang, Z. (2024). Effective Synthesis of C20‐Epi‐Isothiocyanato‐Salinomycin and its Thiourea Derivatives as Potential Anticancer Agents. Chemistry – A European Journal. https://doi.org/10.1002/chem.202402483
Vancouver
Jiang R, Zhang X, Li N, Mao Y, Chen H, Deng Z, et al. Effective Synthesis of C20‐Epi‐Isothiocyanato‐Salinomycin and its Thiourea Derivatives as Potential Anticancer Agents. Chemistry – A European Journal. 2024. doi:10.1002/chem.202402483
BibTeX
@article{Jiang2024,
author = {Jiang, Rui and Zhang, Xin and Li, Na and Mao, Yuyin and Chen, Huan and Deng, Zhouming and Wang, Wentao and Jiang, Zhong-Xing and Xu, Liying and Yang, Zhigang},
title = {Effective Synthesis of C20‐Epi‐Isothiocyanato‐Salinomycin and its Thiourea Derivatives as Potential Anticancer Agents},
journal = {Chemistry – A European Journal},
year = {2024},
doi = {10.1002/chem.202402483}
}
EUVIMED